Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01515 CR MEDICAL
RTNominal down3.450 -0.020 (-0.576%)
Others

02/11/2017 10:16

[I-bank focus]CS starts CR Phoenix Health (01515) at HK$13

[ET Net News Agency, 2 November 2017] Credit Suisse initiated coverage on China
Resources Phoenix Healthcare (CRPHG)(01515) with an "outperform" rating, and a target
price of HK$13.
The research house said CRPHG is the largest hospital group in Asia with 13,135 beds. In
the long run, Credit Suisse believes that the company has the highest potential among
hospital names to benefit from hospital reforms.
It expects that the company will enjoy a healthy and solid growth in the coming years
driven by its unique business model, strong brand name, and continuous M&A efforts. It
said the stock currently is undervalued as compared to other hospital names in the PAC
region. (KL)

Back to Others

Remark: Real time quote last updated: 20/09/2024 16:30
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.